OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony
OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony
Type:
Video
William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.
June 29, 2011
|
June 28, 2011
|
June 27, 2011
|
June 27, 2011
|
June 22, 2011
|
June 21, 2011
|
June 20, 2011
|
June 17, 2011
|
